Bartlett & Co Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.4M | Buy |
116,898
+1,140
| +1% | +$245K | 0.37% | 59 |
|
|
2026
Q1 | $24.3M | Sell |
115,758
-1,138
| -1% | -$252K | 0.31% | 63 |
|
|
2025
Q4 | $26.7M | Sell |
116,896
-1,751
| -1% | -$399K | 0.35% | 60 |
|
|
2025
Q3 | $27.5M | Sell |
118,647
-310
| -0.3% | -$63.1K | 0.36% | 62 |
|
|
2025
Q2 | $22.1M | Sell |
118,957
-1,034
| -0.9% | -$192K | 0.31% | 68 |
|
|
2025
Q1 | $25.1M | Sell |
119,991
-695
| -0.6% | -$135K | 0.37% | 62 |
|
|
2024
Q4 | $21.4M | Sell |
120,686
-1,684
| -1% | -$310K | 0.31% | 66 |
|
|
2024
Q3 | $24.2M | Sell |
122,370
-5,477
| -4% | -$1.02M | 0.35% | 62 |
|
|
2024
Q2 | $21.9M | Buy |
127,847
+4,335
| +4% | +$718K | 0.33% | 64 |
|
|
2024
Q1 | $22.5M | Sell |
123,512
-1,459
| -1% | -$251K | 0.35% | 64 |
|
|
2023
Q4 | $19.3M | Buy |
124,971
+2,049
| +2% | +$299K | 0.31% | 67 |
|
|
2023
Q3 | $18.3M | Sell |
122,922
-1,710
| -1% | -$251K | 0.33% | 68 |
|
|
2023
Q2 | $16.8M | Buy |
124,632
+11,950
| +11% | +$1.75M | 0.29% | 73 |
|
|
2023
Q1 | $18M | Sell |
112,682
-1,458
| -1% | -$223K | 0.35% | 69 |
|
|
2022
Q4 | $18.4M | Sell |
114,140
-72
| -0.1% | -$11K | 0.37% | 69 |
|
|
2022
Q3 | $15.3M | Buy |
114,212
+1,852
| +2% | +$266K | 0.33% | 70 |
|
|
2022
Q2 | $17.2M | Sell |
112,360
-830
| -0.7% | -$127K | 0.35% | 68 |
|
|
2022
Q1 | $18.3M | Buy |
113,190
+1,173
| +1% | +$170K | 0.32% | 74 |
|
|
2021
Q4 | $15.2M | Sell |
112,017
-3,785
| -3% | -$447K | 0.26% | 79 |
|
|
2021
Q3 | $12.5M | Sell |
115,802
-270
| -0.2% | -$30.9K | 0.24% | 83 |
|
|
2021
Q2 | $13.1M | Sell |
116,072
-1,874
| -2% | -$211K | 0.25% | 80 |
|
|
2021
Q1 | $12.8M | Sell |
117,946
-3,175
| -3% | -$340K | 0.26% | 80 |
|
|
2020
Q4 | $13M | Sell |
121,121
-1,111
| -0.9% | -$107K | 0.28% | 74 |
|
|
2020
Q3 | $10.7M | Sell |
122,232
-1,455
| -1% | -$137K | 0.25% | 79 |
|
|
2020
Q2 | $12.1M | Sell |
123,687
-1,525
| -1% | -$134K | 0.32% | 74 |
|
|
2020
Q1 | $9.54M | Sell |
125,212
-3,152
| -2% | -$268K | 0.29% | 80 |
|
|
2019
Q4 | $11.4M | Sell |
128,364
-536
| -0.4% | -$44.5K | 0.28% | 88 |
|
|
2019
Q3 | $9.76M | Buy |
128,900
+18,767
| +17% | +$1.29M | 0.26% | 93 |
|
|
2019
Q2 | $8.01M | Sell |
110,133
-2,300
| -2% | -$181K | 0.3% | 72 |
|
|
2019
Q1 | $9.06M | Sell |
112,433
-4,410
| -4% | -$361K | 0.35% | 68 |
|
|
2018
Q4 | $10.8M | Sell |
116,843
-4,010
| -3% | -$353K | 0.46% | 61 |
|
|
2018
Q3 | $11.4M | Sell |
120,853
-1,561
| -1% | -$148K | 0.43% | 61 |
|
|
2018
Q2 | $11.3M | Buy |
122,414
+175
| +0.1% | +$17.1K | 0.46% | 62 |
|
|
2018
Q1 | $11.6M | Buy |
+122,239
| New | +$13.4M | 0.48% | 64 |
|
Other funds holding ABBV
Bartlett & Co Wealth Management's ABBV Position: Q2 2026 in Review
Bartlett & Co Wealth Management increased its AbbVie (ABBV) stake by 0.98% in Q2 2026, buying an estimated $245K and bringing the position to 116,898 shares worth $29.4M. The position accounts for 0.37% of the portfolio, ranked #59.
Bartlett & Co Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 34 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bartlett & Co Wealth Management held 116,898 shares of AbbVie worth $29.4M as of Q2 2026.
- Bartlett & Co Wealth Management bought 1,140 AbbVie shares in Q2 2026, an estimated $245K.
- AbbVie made up 0.37% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #59 holding.
- Bartlett & Co Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 34 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.